{"id":"W4415742625","doi":"10.1053/j.ajkd.2025.10.004","title":"Effects of Empagliflozin on Urine Biomarkers in EMPA-KIDNEY","year":2025,"lang":"en","type":"article","venue":"American Journal of Kidney Diseases","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network","funders":"Medical Research Council; Centers for Disease Control and Prevention; Universität Zürich; Oxford University Hospitals NHS Foundation Trust; Technische Universität München; Universität Heidelberg; Boehringer Ingelheim; European Society of Cardiology; University of Oxford; Regeneron Pharmaceuticals; National Institutes of Health; U.S. Department of Veterans Affairs; University of Toronto; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Providence Health Care; Kidney Research UK; British Heart Foundation; Eli Lilly and Company; AstraZeneca; National Science Foundation; University of Washington; Novo Nordisk; National Institute for Health and Care Research; Pfizer","keywords":"Empagliflozin; Tamm–Horsfall protein; Kidney; Acute kidney injury; Albuminuria; Kidney disease; Urine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00578494,0.0007607333,0.002045123,0.000298815,0.0002072974,0.0006257145,0.0004029094,0.0009718589,0.002835188],"category_scores_gemma":[0.004620586,0.0003370863,0.002559613,0.0003759287,0.0007714909,0.0003957772,0.0003747526,0.00111571,0.0001587545],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004325407,"about_ca_system_score_gemma":0.0008811065,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005278561,"about_ca_topic_score_gemma":0.0007386165,"domain_scores_codex":[0.9974602,0.001803037,0.0001716423,0.0002259787,0.0002053404,0.0001336438],"domain_scores_gemma":[0.9980243,0.001053153,0.0005641119,0.0001207202,0.00008653355,0.0001512399],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9088241,0.004415731,0.008924135,0.002786597,0.007275849,0.00004053975,0.00004075178,0.001291454,0.003084669,0.0003034447,0.0008122965,0.0622004],"study_design_scores_gemma":[0.7647221,0.1578689,0.05213003,0.0007230371,0.0124543,0.000123073,0.00003321451,0.002686786,0.005105844,0.0009042546,0.00320754,0.0000409423],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9554818,0.03148764,0.003579134,0.001624325,0.0003987774,0.003641627,0.001112551,0.00009414364,0.00258011],"genre_scores_gemma":[0.9900352,0.003342095,0.002557611,0.000721159,0.0002299785,0.002331447,0.0002240041,0.000005869583,0.0005526047],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00578494,"threshold_uncertainty_score":0.03059405,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.003235200058667956,"score_gpt":0.2548581195875118,"score_spread":0.2516229195288438,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}